Comparison of Prasugrel and Ticagrelor in the Treatment of Acute Myocardial Infarction

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1226 participants.

Also called NCT02808767

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 1,226 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02808767
Other papers using this trial's data
  • 1-Year Outcomes of Patients Undergoing Primary Angioplasty for Myocardial Infarction Treated With Prasugrel Versus Ticagrelor Journal of the American College of Cardiology, 2018-01-30 DOI, PubMed 29154813

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Czechia (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02808767. Randomized; single masking; primary purpose treatment. Start 2013-01 (actual); primary completion 2016-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of Prasugrel and Ticagrelor in the Treatment of Acute Myocardial Infarction
Acronym
PRAGUE-18
Condition
Angioplasty, Balloon, Coronary
Condition
Platelet Aggregation Inhibitors
Intervention (Drug)
Prasugrel
Intervention (Drug)
Ticagrelor
Lead sponsor
Faculty Hospital Kralovske Vinohrady (class: other government)

Record details

Record id
cardio:ct-nct02808767
Content hash
0cb0ed64ab0b9f6e137905751633e301c0669d8a8eeea4fea399ec9a88817be7